Jubilant Pharmova’s Board of Directors approved the grant of 1,506 Stock Options/Restricted Stock Units (RSUs) to eligible employees under the Jubilant Pharmova Employees Stock Option Plan 2018. The decision was made during the board meeting held on October 31, 2025. The options will vest after three years and have an exercise price of Re. 1 each.
Stock Option Grant
The Board of Directors of Jubilant Pharmova has approved the grant of 1,506 Stock Options/Restricted Stock Units (RSUs) to eligible employees. This grant is part of the Jubilant Pharmova Employees Stock Option Plan 2018. The approval occurred during the board meeting held on October 31, 2025, which commenced at 11:40 A.M. and concluded at 12:50 P.M.
Key Details of the Stock Options
The grant involves 1,506 equity shares, each with a face value of Re. 1. The exercise price for each option is also Re. 1 per equity share. The options will vest at the end of the 3rd year, subject to fulfilling pre-vesting conditions. Once vested, the options can be exercised within a maximum period of 1 year, according to the terms of the Stock Option Plan 2018.
Vesting Period
The vesting of these options is subject to a minimum period of 1 year and a maximum period of 5 years from the grant date, as stipulated in the Jubilant Pharmova Employees Stock Option Plan 2018.
Source: BSE